Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost. © 2005 Elsevier SAS. All rights reserved.
Correa-Basurto, J., Alcántara, I. V., Espinoza-Fonseca, L. M., & Trujillo-Ferrara, J. G. (2005). p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry, 732-735. https://doi.org/10.1016/j.ejmech.2005.03.011